Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer

被引:41
作者
Peters, N
Domcheck, SM
Rose, A
Polis, R
Stopfer, J
Armstrong, K
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
来源
GENETIC TESTING | 2005年 / 9卷 / 01期
关键词
D O I
10.1089/gte.2005.9.48
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A total of 2,400 questionnaires were mailed to members of two mid-Atlantic breast cancer awareness/support groups to investigate the association between attitudes, knowledge, and use of BRCA1/2 testing among women with early-onset breast cancer. Of the 493 (21%) questionnaires returned, 406 respondents had a diagnosis of breast cancer, of whom 248 were diagnosed prior to age 50 and included in the analyses. Eighty-three percent (206/248) of these women had heard of BRCA1/2 testing and 12.5% (31/248) had undergone BRCA1/2 testing. Among women who had heard of BRCA1/2 testing, women who had been tested were younger (p = 0.03), more likely to have a college education (p = 0.03), more likely to have a family member who had undergone BRCA1/2 testing (p = 0.005), and had greater knowledge, more positive attitudes, and fewer negative attitudes about BRCA1/2 testing (p = 0.02, p = 0.004, and p = 0.004, respectively). In this sample, knowledge regarding BRCA1/2 testing is high, but uptake of genetic testing is low. Lack of information regarding how genetic testing might alter health-care decisions and fear about the genetic testing procedure, its costs, and possible false-positive results are associated with low uptake of genetic testing. Further education regarding these specific points may enhance the use of genetic testing.
引用
收藏
页码:48 / 53
页数:6
相关论文
共 32 条
[1]   Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination [J].
Armstrong, K ;
Weber, B ;
FitzGerald, G ;
Hershey, JC ;
Pauly, MV ;
Lemaire, J ;
Subramanian, K ;
Asch, DA .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 120A (03) :359-364
[2]  
Armstrong K, 2000, CANCER EPIDEM BIOMAR, V9, P1251
[3]   American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility [J].
Bruinooge, SS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2397-2406
[4]   Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer [J].
Cappelli, M ;
Surh, L ;
Humphreys, L ;
Verma, S ;
Logan, D ;
Hunter, A ;
Allanson, J .
CLINICAL GENETICS, 1999, 55 (06) :419-430
[5]   The Oncormed approach to genetic testing [J].
Carter, CL ;
Scott, JA ;
Glauber, PM ;
Murphy, PD .
GENETIC TESTING, 1997, 1 (02) :137-144
[6]   BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer [J].
Couch, FJ ;
DeShano, ML ;
Blackwood, MA ;
Calzone, K ;
Stopfer, J ;
Campeau, L ;
Ganguly, A ;
Rebbeck, T ;
Weber, BL ;
Jablon, L ;
Cobleigh, MA ;
Hoskins, K ;
Garber, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) :1409-1415
[7]   Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients:: A population-based study [J].
de Sanjosé, S ;
Léoné, M ;
Bérez, V ;
Izquierdo, A ;
Font, R ;
Brunet, JM ;
Louat, T ;
Vilardell, L ;
Borras, J ;
Viladiu, P ;
Bosch, FX ;
Lenoir, GM ;
Sinilnikova, OM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) :588-593
[8]   Application of breast cancer risk prediction models in clinical practice [J].
Domchek, SM ;
Eisen, A ;
Calzone, K ;
Stopfer, J ;
Blackwood, A ;
Weber, BL .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) :593-601
[9]   THE GENETICS OF BREAST AND OVARIAN-CANCER [J].
FORD, D ;
EASTON, DF .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :805-812
[10]   A 40-year-old woman with a strong family history of breast cancer [J].
Garber, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (20) :1953-1960